Physician profile
Kush K Goyal
NPI 1679777528
$21,881.73
in general payments reported to CMS, 2019-2025
21 companies · $1,846 in 2025
The $1,846 reported for 2025 was more than what 84% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $863 · 2020: $160 · 2021: $235 · 2022: $500 · 2023: $13K · 2024: $5,597 · 2025: $1,846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $3,221 · Travel and Lodging: $2,503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,400.00 |
| Food and Beverage | $3,220.86 |
| Travel and Lodging | $2,503.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $17,918.95 | 2021-2025 | |
| Boston Scientific Corporation | $945.68 | 2019-2025 | General - Pain Management |
| Spr Therapeutics, INC | $465.18 | 2019-2025 | Sprint Pns System |
| Nevro Corp. | $379.62 | 2022-2024 | Senza |
| Mml US, INC. | $360.07 | 2024-2025 | Reactiv8 |
| Radius Health, INC. | $240.55 | 2019 | |
| Stryker Corporation | $230.48 | 2019-2024 | Spinejack |
| Relievant Medsystems, INC. | $201.50 | 2019-2023 | Intracept |
| Avanos Medical | $190.68 | 2021-2022 | |
| Globus Medical, INC. | $153.80 | 2025 | Si-Lok, Excelsius Gps |
| Medtronic, INC. | $144.77 | 2023 | Intellis Adaptivestim |
| Abbott Laboratories | $135.15 | 2024 | Proclaim |
| Janssen Scientific Affairs, LLC | $125.00 | 2019 | |
| Ucb, INC. | $106.17 | 2023 | |
| Xeris Pharmaceuticals, INC. | $74.02 | 2023 | Gvoke Hypopen |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tonix Medicines, INC. | $67.35 | 2025 | Tonmya |
| Curonix LLC | $60.59 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pfizer INC. | $37.55 | 2021 | |
| Novo Nordisk INC | $16.41 | 2023 | Rybelsus, Ozempic |
| Sonex Health, INC. | $15.38 | 2021 | |
| Dexcom, INC. | $12.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kush Goyal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.